Previous research has demonstrated that CMV infection impairs vaccine immunogenicity through a reduction in antigen-specific IgG and T cell IFN-γ induced by influenza and Ebola virus vaccines (6, 10, 37). The gene discussed is IFNG; the disease is cytomegalovirus infection.